<DOC>
	<DOCNO>NCT02072759</DOCNO>
	<brief_summary>Insulin resistant subject type 2 diabetic patient characterize decreased metabolic flexibility : reduce capability switch fat oxidation basal state carbohydrate oxidation insulin-stimulated state . This metabolic inflexibility early hallmark development diabetes . Recent evidence suggest low carnitine availability may limit acetylcarnitine formation , thereby reduce metabolic flexibility . We propose test hypothesis metabolic inflexibility pre-diabetic subject diabetic patient due reduce capacity form acetylcarnitines .</brief_summary>
	<brief_title>Acetylcarnitine Metabolic Flexibility</brief_title>
	<detailed_description>Background : Insulin resistant subject type 2 diabetic patient characterize decreased metabolic flexibility : reduce capability switch fat oxidation basal state carbohydrate oxidation insulin-stimulated state . This metabolic inflexibility early hallmark development diabetes . Recent evidence suggest low carnitine availability may limit acetylcarnitine formation , thereby reduce metabolic flexibility . Objectives : We investigate whether subject impair glucose tolerance ( IGT ) show diminished capacity form acetylcarnitine face high substrate availability . Therefore , use novel non-invasive 1H-Magnetic Resonance Spectroscopy ( 1H-MRS ) protocol determine vivo , time , formation acetylcarnitine skeletal muscle . Additionally , examine whether carnitine supplementation increase capacity form acetylcarnitine improve metabolic flexibility insulin sensitivity IGT subject . Study design : 12 subject IGT include subject either placebo- carnitine treatment ( daily capsule 2g L-carnitine placebo ) randomize , placebo-controlled , double blind crossover design . After intervention , acetylcarnitine formation mixed meal determine 1H-MRS meal-induced change fat glucose oxidation indirect calorimetry . The maximal acetylcarnitine formation measure cycling test via 1H-MRS. A hyperinsulinemic-euglycemic clamp perform determine insulin sensitivity . Biopsies take measure free carnitine carnitine acetyltransferase ( CrAT ) activity . To investigate whether difference acetylcarnitine formation may involve variation glucose tolerance , twelve control subject , match BMI age glucose tolerant ( base oral glucose tolerance test , accord WHO criterion ) also include undergo measurement without intervention .</detailed_description>
	<mesh_term>Glucose Intolerance</mesh_term>
	<mesh_term>Acetylcarnitine</mesh_term>
	<criteria>Age 4070 year Overweight/obese , BMI 2535 kg/m2 Stable dietary habit Generally healthy medication use interfere metabolism Fasting plasma glucose &gt; 7.1 mmol/l Haemoglobin &lt; 7.8 mmol/l Hypertension : blood pressure &gt; 140 mmHg systolic 90 mmHg diastolic Cardiac problem , angina pectoris , cardiac infarction arrhythmia Plasma creatinine concentration high 115 micromol/l ( men ) en 100 micromol ( woman ) . Any medical condition require treatment and/or medication interferes investigate parameter Unstable body weight ( weight gain loss &gt; 3 kg past three month ) Participation another biomedical study within 1 month prior screen visit Subjects contraindication MRI Subjects , want inform unexpected medical finding , wish treat physician inform , participate study . Subject allow donate blood three month prior start study three month finish study .</criteria>
	<gender>All</gender>
	<minimum_age>40 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>June 2015</verification_date>
	<keyword>Insulin sensitivity</keyword>
	<keyword>Metabolic flexibility</keyword>
</DOC>